Results 11 to 20 of about 7,400 (167)

Intranasal administration of dantrolene increased brain concentration and duration

open access: yesPLoS ONE, 2020
Dantrolene has been demonstrated to be neuroprotective for multiple neurodegenerative diseases. However, dantrolene’s limited penetration into the CNS hampers its effectiveness as a neuroprotective agent.
Qingcheng Meng (8561451)   +16 more
core   +2 more sources

Dantrolene use across surgical and medical care at Mayo Clinic from 2010 to 2024: Indications, frequency, and value for identifying malignant hyperthermia. [PDF]

open access: yesBiomol Biomed
Dantrolene is the definitive treatment for malignant hyperthermia (MH), a rare and life-threatening disorder. This retrospective study aimed to achieve two objectives: (1) to characterize the indications and frequency of dantrolene administration in both
Cho D   +5 more
europepmc   +4 more sources

Functional recovery after dantrolene-supplementation of cold stored hearts using an ex vivo isolated working rat heart model. [PDF]

open access: yesPLoS ONE, 2018
The ryanodine receptor antagonist dantrolene inhibits calcium release from the sarcoplasmic reticulum and reduces cardiac ischaemia-reperfusion injury (IRI) in global warm ischaemia models however the cardioprotective potential of dantrolene under ...
Villanueva, JE   +21 more
core   +3 more sources

Dantrolene enhances the protective effect of hypothermia on cerebral cortex neurons

open access: yesNeural Regeneration Research, 2015
Therapeutic hypothermia is the most promising non-pharmacological neuroprotective strategy against ischemic injury. However, shivering is the most common adverse reaction. Many studies have shown that dantrolene is neuroprotective in in vitro and in vivo
Lei Chen   +6 more
core   +2 more sources

Dantrolene: A Selective Ryanodine Receptor Antagonist, Protects Against Pentylenetetrazole-Induced Seizure in Mice

open access: yesActa Medica Iranica, 2016
Ryanodine receptor abnormalities has implicated in the generation and maintenance of seizure. Dantrolene, a selective ryanodine receptor antagonist, may be a potential drug for the prevention of seizure.
Alireza Rasti   +2 more
core   +1 more source

Structural identification of the RY12 domain of RyR1 as an ADP sensor and the target of the malignant hyperthermia therapeutic dantrolene. [PDF]

open access: yesNat Commun
Malignant hyperthermia (MH) is a pharmacogenetic condition triggered by volatile anesthetics, which activate MH susceptible mutants of ryanodine receptor 1 (RyR1).
Kim K   +9 more
europepmc   +2 more sources

Intravenous dantrolene in hypermetabolic syndromes: a survey of the U.S. Veterans Health Administration database

open access: yesBMC Anesthesiology, 2022
Background Intravenous dantrolene is often prescribed for hypermetabolic syndromes other than the approved indication of malignant hyperthermia (MH). To clarify the extent of and indications for dantrolene use in conditions other than MH, we sought to ...
Stanley N. Caroff   +7 more
doaj   +1 more source

Pharmacokinetics of Dantrolene in the Plasma Exchange Treatment of Malignant Hyperthermia in a 14-Year-Old Chinese Boy: A Case Report and Literature Review

open access: yesFrontiers in Medicine, 2022
Malignant hyperthermia (MH) is a rare life-threatening response that is triggered by exposure to specific anesthetics commonly used during surgical interventions. Dantrolene is a well-known drug used as the first-line therapy for MH.
Xiaoxiao Li   +15 more
doaj   +1 more source

Dantrolene prevents hepatic steatosis by reducing cytoplasmic Ca2+ level and ER stress

open access: yesBiochemistry and Biophysics Reports, 2020
Introduction: Our previous studies demonstrated that dantrolene, a ryanodine receptor stabilizer, prevents endoplasmic reticulum (ER) stress in the heart.
Masaki Tamitani   +12 more
doaj   +1 more source

Use of extracorporeal cardiopulmonary resuscitation in malignant hyperthermia-induced sudden cardiac arrest - A case study. [PDF]

open access: yesSaudi J Anaesth
Malignant hyperthermia is a rare but potentially fatal complication of general anesthesia caused by inhalational anesthetics and depolarizing skeletal muscle relaxants.
Woźnica-Niesobska E   +3 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy